BioMarin Pharmaceutical selects SAP S/4 HANA for ERP Financial

In 2022, BioMarin Pharmaceutical, a United States based Life Sciences organization with 3401 employees and revenues of $2.4B selected SAP S/4 HANA for ERP Financial while displacing Legacy, and integrating with the existing systems being used.

Customer	Vendor	Old Product	New Product	Category	Market	Users	VAR/SI	When	Live
BioMarin Pharmaceutical	SAP	Legacy	SAP S/4 HANA	ERP Financial	ERP Financial Management	n/a	n/a	2022	2024

Discover the latest software purchases and digital transformation initiatives being undertaken by BioMarin Pharmaceutical and its business and technology executives by accessing the entire BioMarin Pharmaceutical and its business and technology executives by becoming a Premium Subscriber. On a continuous basis, our research team identifies and updates the on-prem and cloud applications that are being used by BioMarin Pharmaceutical employees from publicly available data (Press Releases, Customer References, Case Studies, Success Stories, Testimonials, RFP, RFI, etc.) as well as proprietary sources, and incorporate them into the customer profile.